Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE)
Clinical trial NCT02134028 · COMPLETED
Trial details
- NCT number
- NCT02134028
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-05
- Primary completion
- 2019-10-11
- Enrollment
- 2282
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.